KRAS and cancer: The correlation between NT5E expression level and mutational status also was investigated across a panel of 474 cancer cell lines from the Cancer Cell Line Encyclopedia (CCLE) [39] demonstrating a positive correlation between CD73 mRNA level and KRAS and BRAF mutational status but not TP53 [40].